SCOPUS 정보 검색 플랫폼

Volumn 24, Issue 7 SUPPL. 2, 2001, Pages

Treating mixed dyslipidemias: Why and how

a BAYLOR COLLEGE OF MEDICINE (United States)

Author keywords

Dyslipidemias; High density lipoprotein cholesterol; Low density lipoprotein cholesterol; National Cholesterol Education Program; Statin

Indexed keywords

CERIVASTATIN; ESTROGEN; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; SIMVASTATIN; STATINE DERIVATIVE; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; COST CONTROL; DISEASE COURSE; DRUG INDUCED DISEASE; DYSLIPIDEMIA; EDUCATION PROGRAM; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; META ANALYSIS;

EID: 0034968795 PISSN: 01609289 EISSN: None Source Type: Journal
DOI: 10.1002/clc.4960240704 Document Type: Conference Paper

Times cited : (9)

References (24)

1
- 0032510639
- Prediction of coronary heart disease using risk factor categories
- (1998) Circulation , vol.97 , pp. 1837-1847
- Wilson, P.W.F.¹ D'Agostino, R.B.² Levy, D.³ Belanger, A.M.⁴ Silbershatz, H.⁵ Kannel, W.B.⁶

2
- 0027243348
- Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
- (1993) JAMA , vol.269 , pp. 3015-3023

3
- 0034621642
- Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data
- (2000) Arch Intern Med , vol.160 , pp. 1361-1369
- Jacobson, T.A.¹ Griffiths, G.G.² Varas, C.³ Gause, D.⁴ Sung, J.C.Y.⁵ Ballantyne, C.M.⁶

4
- 0029741921
- A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
- (1996) JAMA , vol.276 , pp. 882-888
- Stampfer, M.J.¹ Krauss, R.M.² Ma, J.³ Blanche, P.J.⁴ Holl, L.G.⁵ Sacks, F.M.⁶ Hennekens, C.H.⁷

5
- 0033527030
- Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
- (1999) N Engl J Med , vol.341 , pp. 410-418
- Rubins, H.B.¹ Robins, S.J.² Collins, D.³ Fye, C.L.⁴ Anderson, J.W.⁵ Elam, M.B.⁶ Faas, F.H.⁷ Linares, E.⁸ Schaefer, E.J.⁹ Schectman, G.¹⁰ Wilt, T.J.¹¹ Wittes, J.¹²

6
- 0026091744
- A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction
- (1991) N Engl J Med , vol.325 , pp. 373-381
- Stampfer, M.J.¹ Sacks, F.M.² Salvini, S.³ Willett, W.C.⁴ Hennekens, C.H.⁵

7
- 0027124612
- The primary prevention of myocardial infarction
- (1992) N Engl J Med , vol.326 , pp. 1406-1416
- Manson, J.E.¹ Tosteson, H.² Ridker, P.M.³ Satterfield, S.⁴ Hebert, P.⁵ O'Connor, G.T.⁶ Buring, J.E.⁷ Hennekens, C.H.⁸

8
- 0030841001
- Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])
- (1997) Am J Cardiol , vol.80 , pp. 278-286
- Herd, J.A.¹ Ballantyne, C.M.² Farmer, J.A.³ Ferguson III, J.J.⁴ Jones, P.H.⁵ West, M.S.⁶ Gould, K.L.⁷ Gotto A.M., Jr.⁸

9
- 0032912006
- Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy
- (1999) Circulation , vol.99 , pp. 736-743
- Ballantyne, C.M.¹ Herd, J.A.² Ferlic, L.L.³ Dunn, J.K.⁴ Farmer, J.A.⁵ Jones, P.H.⁶ Schein, J.R.⁷ Gotto A.M., Jr.⁸

10
- 0027987849
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
- (1994) Lancet , vol.344 , pp. 1383-1389

11
- 0028883828
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
- (1995) N Engl J Med , vol.333 , pp. 1301-1307
- Shepherd, J.¹ Cobbe, S.M.² Ford, I.³ Isles, G.G.⁴ Lorimer, A.R.⁵ Macfarlane, P.W.⁶ McKillop, J.H.⁷ Packard, C.J.⁸

12
- 0342981862
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
- (1996) N Engl J Med , vol.335 , pp. 1001-1009
- Sacks, F.M.¹ Pfeffer, M.A.² Moyé, L.A.³ Rouleau, J.L.⁴ Rutherford, J.D.⁵ Cole, T.G.⁶ Brown, L.⁷ Warnica, J.W.⁸ Arnold, J.M.O.⁹ Wun, C.-C.¹⁰ Davis, B.R.¹¹ Braunwald, E.¹²

13
- 0032920672
- Influence of baseline lipids on effectiveness of pravastatin in the CARE trial
- (1999) J Am Coll Cardiol , vol.33 , pp. 125-130
- Pfeffer, M.A.¹ Sacks, F.M.² Moyé, L.A.³ Fast, C.⁴ Goldman, S.⁵ Nash, D.T.⁶ Rouleau, J.R.⁷ Rouleau, J.L.⁸ Sussex, P.A.⁹ Théroux, P.¹⁰ Vanden Belt, R.J.¹¹ Braunwald, E.¹²

14
- 0032487931
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
- (1998) N Engl J Med , vol.339 , pp. 1349-1357

15
- 0032572086
- Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS
- (1998) JAMA , vol.279 , pp. 1615-1622
- Downs, J.R.¹ Clearfield, M.² Weis, S.³ Whitney, E.⁴ Shapiro, D.R.⁵ Beere, P.A.⁶ Langendorfer, A.⁷ Stein, E.A.⁸ Kruyer, W.⁹ Gotto A.M., Jr.¹⁰

16
- 0034663703
- Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia
- (2000) Am J Cardiol , vol.86 , pp. 406-411
- Stein, E.¹ Plotkin, D.² Bays, A.³ Davidson, M.⁴ Dujovne, C.⁵ Korenman, S.⁶ Stepanavase, M.⁷ Mercuri, M.⁸

17
- 0035082566
- Efficacy and tolerability of fluvastatin extended-release delivery system: A pooled analysis
- (2001) Clin Ther , vol.23 , pp. 177-192
- Ballantyne, C.M.¹ Pazzucconi, F.² Pintó, X.³ Reckless, J.P.⁴ Stein, E.⁵ McKenney, J.⁶ Bortolini, M.⁷ Chiang, Y.T.⁸

18
- 0029982038
- Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
- (1996) Lancet , vol.347 , pp. 849-853
- Ericsson, C.-G.¹ Hamsten, A.² Nilsson, J.³ Grip, L.⁴ Svane, B.⁵ De Faire, U.⁶

19
- 0342506477
- Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol
- (1997) Circulation , vol.96 , pp. 2137-2143
- Frick, M.H.¹ Syvänne, M.² Nieminen, M.S.³ Kauma, H.⁴ Majahalme, S.⁵ Virtanen, V.⁶ Kesäniemi, A.⁷ Pastemack, A.⁸ Taskinen, M.-R.⁹

20
- 0034604225
- Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease
- (2000) Circulation , vol.102 , pp. 21-37

21
- 0034710627
- Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
- (2000) N Engl J Med , vol.343 , pp. 522-529
- Herrington, D.M.¹ Reboussin, D.M.² Brosnihan, K.B.³ Sharp, P.C.⁴ Shumaker, S.A.⁵ Snyder, T.E.⁶ Furberg, C.D.⁷ Kowalchuk, G.J.⁸ Stuckey, T.D.⁹ Rogers, W.J.¹⁰ Givens, D.H.¹¹ Waters, D.¹²

22
- 0032547326
- Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
- (1998) JAMA , vol.280 , pp. 605-613
- Hulley, S.¹ Grady, D.² Bush, T.³ Furberg, C.⁴ Herrington, D.⁵ Riggs, B.⁶ Vittinghoff, E.⁷

23
- 0031785586
- Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterol
- (1998) Prog Cardiovasc Dis , vol.41 , pp. 151-174
- Belalcazar, L.M.¹ Ballantyne, C.M.²

24
- 4243209632
- West Haven, Conn.: Bayer Corp.
- (2000) Baycol® (cerivastatin sodium) tablets (package insert)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.